Everand Logo

Welcome to Everand!

  • STAT

    Moderna receives $176 million from BARDA for mRNA influenza vaccines

    Moderna will receive $176 million from HHS' BARDA to accelerate development of mRNA-based pandemic influenza vaccines, the company said Tuesday.
    by Helen Branswell Jul 02, 2024 1 minute
    Source: Ruby Wallau for STAT

    Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Freespira Bets On Slow And Steady, Amid Spectacular Digital Health Collapses
    Freespira, which makes a digital treatment for panic and post-traumatic stress disorders, expects to break even by the end of 2025.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly Lawsuits, Novo Nordisk Fires And Much More
    For the third time in a month, Novo Nordisk has been affected by an office fire. A Novo Nordisk spokesman told a local newspaper “there is nothing to suggest that…
    STAT1 min read
    STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
    The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.

    Related Books & Audiobooks